Male condom sales in the United States increased 23.4 percent to $37 million during the four weeks ending April 18 from the same period last year.
The figure still represents a 4.4 percent drop in all of 2020.
The condom maker attributed recent growth to relaxed social distancing rules, with CEO Laxman Narasimhan revealing that they saw improved sales in markets where social restrictions are being eased.
Condom sales plummeted during the pandemic as people stayed at home. But as more are getting vaccinated and Covid-19 safety restrictions are loosening, condom sales went up.
Durex sales still grew last year, despite a challenging first half of 2020 and flat sales in 2019.
Britta Bomhard, chief marketing officer of Church & Dwight (CHD), the maker of Trojan condoms, noted that 18-to 24-year-olds can't wait to get their social lives back.
Condoms sales, says CHD CEO Matt Farrell, are expected to grow on-year as society opens up and consumers become more mobile.
Even before the pandemic, condom sales dropped 2.4 percent in 2017 and 3.4 percent in 2018 before climbing 1.2 percent in 2019.
Kevin Grundy, a consumer goods analyst at Jefferies, attributed condoms' lower market share in recent years to competition posed by other forms of contraception, including women's morning-after pill.
Researchers from Indiana University and Sweden's Karolinska Institutet attributed young Americans having less sex to a variety of factors, including delayed adulthood and the rise of technology and social media.
Men who were unemployed, had part-time employment or lower incomes were more likely to be sexually inactive, researchers found.


Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Uber Stock Falls as Waymo Plans to End Robotaxi Partnership by 2028
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
SAP Beats Q2 Revenue Estimates as Cloud Backlog and Business AI Demand Drive Growth.
Coca-Cola Raises Diet Coke Prices in India as Iran Conflict Disrupts Can Supply
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
SpaceX Stock Slump Wipes Out Nearly $700 Billion From Elon Musk’s Paper Wealth
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 



